 Bahram Salmanian
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta Accreta | 18 | 2023 | 27 | 6.980 |
Why?
| | Placenta Previa | 7 | 2022 | 9 | 2.210 |
Why?
| | Cesarean Section | 16 | 2023 | 183 | 2.000 |
Why?
| | Hysterectomy | 11 | 2022 | 120 | 1.420 |
Why?
| | Pre-Eclampsia | 4 | 2025 | 185 | 1.240 |
Why?
| | Pregnancy | 41 | 2025 | 6375 | 1.190 |
Why?
| | Fertilization in Vitro | 3 | 2021 | 76 | 1.010 |
Why?
| | Albuminuria | 1 | 2025 | 181 | 0.880 |
Why?
| | Fetal Diseases | 4 | 2015 | 156 | 0.730 |
Why?
| | Blood Transfusion | 3 | 2023 | 293 | 0.690 |
Why?
| | Placenta | 9 | 2023 | 716 | 0.610 |
Why?
| | Hydrothorax | 1 | 2014 | 3 | 0.450 |
Why?
| | Cardiac Tamponade | 1 | 2014 | 14 | 0.450 |
Why?
| | Female | 44 | 2025 | 68519 | 0.440 |
Why?
| | Fetofetal Transfusion | 3 | 2022 | 20 | 0.430 |
Why?
| | Retrospective Studies | 22 | 2023 | 14571 | 0.430 |
Why?
| | Postpartum Hemorrhage | 3 | 2023 | 16 | 0.410 |
Why?
| | Blood Component Transfusion | 3 | 2021 | 79 | 0.390 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 204 | 0.360 |
Why?
| | Ultrasonography, Prenatal | 6 | 2019 | 270 | 0.330 |
Why?
| | Humans | 44 | 2025 | 129136 | 0.310 |
Why?
| | Pregnancy Outcome | 8 | 2022 | 389 | 0.300 |
Why?
| | Blood Loss, Surgical | 4 | 2019 | 91 | 0.250 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2023 | 364 | 0.250 |
Why?
| | Astigmatism | 2 | 2016 | 10 | 0.250 |
Why?
| | Sterilization, Tubal | 2 | 2015 | 13 | 0.250 |
Why?
| | Photorefractive Keratectomy | 2 | 2016 | 19 | 0.240 |
Why?
| | Myopia | 2 | 2016 | 47 | 0.240 |
Why?
| | Social Justice | 2 | 2015 | 77 | 0.230 |
Why?
| | Nuchal Translucency Measurement | 2 | 2013 | 2 | 0.220 |
Why?
| | Laser Therapy | 2 | 2015 | 130 | 0.210 |
Why?
| | Adult | 23 | 2023 | 35513 | 0.210 |
Why?
| | Creatinine | 1 | 2025 | 475 | 0.210 |
Why?
| | Delivery, Obstetric | 2 | 2016 | 137 | 0.200 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2023 | 68 | 0.200 |
Why?
| | Cohort Studies | 7 | 2022 | 5407 | 0.200 |
Why?
| | Chorioamnionitis | 1 | 2022 | 39 | 0.200 |
Why?
| | Prenatal Diagnosis | 2 | 2021 | 190 | 0.190 |
Why?
| | Erythrocyte Transfusion | 3 | 2019 | 182 | 0.190 |
Why?
| | Incidence | 3 | 2025 | 2635 | 0.190 |
Why?
| | Betamethasone | 2 | 2012 | 20 | 0.190 |
Why?
| | Obstetric Labor Complications | 1 | 2022 | 29 | 0.190 |
Why?
| | Obstetric Labor, Premature | 2 | 2012 | 35 | 0.190 |
Why?
| | Apgar Score | 1 | 2021 | 17 | 0.190 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 20 | 0.190 |
Why?
| | Obstetrics | 1 | 2023 | 161 | 0.190 |
Why?
| | Urologic Diseases | 1 | 2021 | 38 | 0.180 |
Why?
| | Embryo Transfer | 1 | 2021 | 33 | 0.180 |
Why?
| | Gestational Age | 7 | 2022 | 868 | 0.180 |
Why?
| | Umbilical Arteries | 1 | 2021 | 51 | 0.180 |
Why?
| | Labor, Obstetric | 1 | 2021 | 59 | 0.180 |
Why?
| | Anemia | 1 | 2022 | 161 | 0.170 |
Why?
| | Intraoperative Complications | 1 | 2021 | 132 | 0.170 |
Why?
| | Premature Birth | 2 | 2022 | 312 | 0.170 |
Why?
| | Social Determinants of Health | 1 | 2023 | 220 | 0.170 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 1943 | 0.160 |
Why?
| | Infant, Newborn | 9 | 2022 | 5739 | 0.160 |
Why?
| | Hypocalcemia | 1 | 2019 | 28 | 0.160 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 79 | 0.150 |
Why?
| | Placenta, Retained | 2 | 2017 | 2 | 0.150 |
Why?
| | Heart Defects, Congenital | 2 | 2017 | 741 | 0.150 |
Why?
| | Patient Care Team | 3 | 2019 | 602 | 0.150 |
Why?
| | Fetoscopy | 2 | 2015 | 27 | 0.150 |
Why?
| | Risk Factors | 7 | 2023 | 9769 | 0.150 |
Why?
| | Placenta Diseases | 1 | 2018 | 14 | 0.150 |
Why?
| | Lasers, Excimer | 2 | 2016 | 29 | 0.140 |
Why?
| | Severity of Illness Index | 2 | 2023 | 2739 | 0.140 |
Why?
| | Hydrops Fetalis | 1 | 2017 | 13 | 0.140 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2017 | 36 | 0.140 |
Why?
| | Odds Ratio | 1 | 2020 | 1025 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2020 | 479 | 0.140 |
Why?
| | Infertility, Female | 1 | 2017 | 105 | 0.130 |
Why?
| | Hemorrhage | 1 | 2021 | 645 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1496 | 0.130 |
Why?
| | Vasa Previa | 1 | 2015 | 2 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2017 | 187 | 0.130 |
Why?
| | Lymphatic Abnormalities | 1 | 2015 | 19 | 0.120 |
Why?
| | Young Adult | 8 | 2023 | 12389 | 0.120 |
Why?
| | Renal Veins | 1 | 2015 | 15 | 0.120 |
Why?
| | Whooping Cough | 1 | 2015 | 48 | 0.120 |
Why?
| | Tachycardia, Supraventricular | 1 | 2015 | 43 | 0.120 |
Why?
| | Treatment Outcome | 7 | 2018 | 10227 | 0.120 |
Why?
| | Birth Weight | 4 | 2022 | 499 | 0.120 |
Why?
| | Corneal Pachymetry | 1 | 2014 | 14 | 0.110 |
Why?
| | Fetal Therapies | 1 | 2014 | 32 | 0.110 |
Why?
| | Hernia, Diaphragmatic | 1 | 2014 | 69 | 0.110 |
Why?
| | Biomarkers | 1 | 2025 | 3897 | 0.110 |
Why?
| | Cornea | 1 | 2014 | 114 | 0.110 |
Why?
| | Venous Thrombosis | 1 | 2015 | 162 | 0.100 |
Why?
| | Clinical Protocols | 1 | 2014 | 254 | 0.100 |
Why?
| | Thyroxine | 1 | 2013 | 62 | 0.100 |
Why?
| | Receptors, Opioid, mu | 1 | 2013 | 57 | 0.100 |
Why?
| | Placental Circulation | 1 | 2013 | 63 | 0.100 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 138 | 0.100 |
Why?
| | Cervix Uteri | 1 | 2012 | 51 | 0.100 |
Why?
| | Morphine | 1 | 2013 | 129 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 471 | 0.100 |
Why?
| | Uterine Cervical Diseases | 1 | 2011 | 6 | 0.090 |
Why?
| | Urinary Incontinence, Stress | 1 | 2010 | 14 | 0.090 |
Why?
| | Liver Diseases | 1 | 2014 | 285 | 0.090 |
Why?
| | Laparoscopy | 1 | 2015 | 454 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 2013 | 491 | 0.080 |
Why?
| | United States | 3 | 2022 | 13941 | 0.080 |
Why?
| | Laser Coagulation | 2 | 2022 | 57 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 490 | 0.080 |
Why?
| | Fetal Growth Retardation | 1 | 2014 | 543 | 0.080 |
Why?
| | Fullerenes | 1 | 2008 | 17 | 0.080 |
Why?
| | Porphyrins | 1 | 2008 | 21 | 0.080 |
Why?
| | Magnetics | 1 | 2008 | 44 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2023 | 3342 | 0.080 |
Why?
| | Magnesium | 1 | 2008 | 151 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2496 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2013 | 886 | 0.070 |
Why?
| | Maternal Age | 2 | 2017 | 123 | 0.070 |
Why?
| | Cytokines | 2 | 2012 | 1987 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 471 | 0.060 |
Why?
| | Pregnancy, Twin | 2 | 2016 | 18 | 0.060 |
Why?
| | Iran | 2 | 2016 | 38 | 0.060 |
Why?
| | Nanoparticles | 1 | 2008 | 368 | 0.060 |
Why?
| | Placentation | 2 | 2015 | 44 | 0.060 |
Why?
| | Pregnancy Trimester, Second | 2 | 2014 | 79 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1825 | 0.050 |
Why?
| | Myocardium | 1 | 2008 | 973 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3955 | 0.050 |
Why?
| | Texas | 1 | 2023 | 227 | 0.050 |
Why?
| | Child | 1 | 2022 | 20806 | 0.050 |
Why?
| | Cardiotocography | 1 | 2021 | 3 | 0.050 |
Why?
| | Blood Gas Analysis | 1 | 2021 | 71 | 0.050 |
Why?
| | Pregnant Women | 1 | 2022 | 114 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2017 | 5070 | 0.040 |
Why?
| | Acidosis | 1 | 2021 | 88 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2668 | 0.040 |
Why?
| | Iron | 1 | 2022 | 283 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 30 | 0.040 |
Why?
| | Family | 1 | 2023 | 648 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2019 | 60 | 0.040 |
Why?
| | Perinatal Mortality | 1 | 2017 | 12 | 0.040 |
Why?
| | Plasma | 1 | 2019 | 201 | 0.040 |
Why?
| | Isotonic Solutions | 1 | 2017 | 37 | 0.030 |
Why?
| | Breech Presentation | 1 | 2016 | 1 | 0.030 |
Why?
| | Emergencies | 1 | 2017 | 162 | 0.030 |
Why?
| | Refraction, Ocular | 1 | 2016 | 36 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2016 | 4915 | 0.030 |
Why?
| | Polyhydramnios | 1 | 2015 | 17 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 110 | 0.030 |
Why?
| | Fetal Death | 1 | 2014 | 56 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 302 | 0.030 |
Why?
| | Abortion, Eugenic | 1 | 2013 | 3 | 0.030 |
Why?
| | Karyotype | 1 | 2013 | 17 | 0.030 |
Why?
| | Twins, Monozygotic | 1 | 2014 | 209 | 0.030 |
Why?
| | Thyroid Function Tests | 1 | 2013 | 14 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3033 | 0.030 |
Why?
| | Prenatal Care | 1 | 2015 | 274 | 0.030 |
Why?
| | Thyrotropin | 1 | 2013 | 109 | 0.030 |
Why?
| | Nitrites | 1 | 2013 | 81 | 0.030 |
Why?
| | Hypothyroidism | 1 | 2013 | 71 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1979 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 87 | 0.030 |
Why?
| | Tomography, Optical Coherence | 1 | 2014 | 187 | 0.020 |
Why?
| | Rats | 2 | 2013 | 5175 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2013 | 232 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2017 | 608 | 0.020 |
Why?
| | Prospective Studies | 2 | 2016 | 7079 | 0.020 |
Why?
| | Reference Values | 1 | 2013 | 780 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 724 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 162 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2013 | 148 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3788 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 201 | 0.020 |
Why?
| | Parity | 1 | 2010 | 121 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 31080 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 828 | 0.020 |
Why?
| | Fetal Development | 1 | 2013 | 283 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 811 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 500 | 0.020 |
Why?
| | Interleukins | 1 | 2011 | 245 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1124 | 0.020 |
Why?
| | Neutron Diffraction | 1 | 2008 | 3 | 0.020 |
Why?
| | Scattering, Small Angle | 1 | 2008 | 20 | 0.020 |
Why?
| | Isotopes | 1 | 2008 | 28 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 634 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2008 | 142 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2008 | 115 | 0.020 |
Why?
| | Postpartum Period | 1 | 2010 | 330 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2246 | 0.020 |
Why?
| | Drug Discovery | 1 | 2008 | 130 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2008 | 398 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2008 | 538 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2011 | 1865 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1192 | 0.020 |
Why?
| | Kidney | 1 | 2013 | 1308 | 0.020 |
Why?
| | Heart | 1 | 2008 | 639 | 0.010 |
Why?
| | Time Factors | 1 | 2015 | 6518 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3383 | 0.010 |
Why?
| | Oxygen | 1 | 2008 | 902 | 0.010 |
Why?
| | Adolescent | 2 | 2012 | 20302 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 854 | 0.010 |
Why?
| | Hypoxia | 1 | 2008 | 1036 | 0.010 |
Why?
| | Animals | 2 | 2013 | 34610 | 0.010 |
Why?
| | Male | 2 | 2014 | 63203 | 0.010 |
Why?
|
|
Salmanian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|